Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,577,393
-
Total 13F shares
-
12,794,219
-
Share change
-
+4,432,832
-
Total reported value
-
$28,397,554
-
Put/Call ratio
-
9.5%
-
Price per share
-
$2.22
-
Number of holders
-
89
-
Value change
-
+$5,434,902
-
Number of buys
-
60
-
Number of sells
-
26
Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q2 2024
As of 30 Jun 2024,
Cardiff Oncology, Inc. - Common Stock (CRDF) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,794,219 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Assenagon Asset Management S.A., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MAI Capital Management, MORGAN STANLEY, MARSHALL WACE, LLP, BIT Capital GmbH, and MILLENNIUM MANAGEMENT LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.